These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 16324199
1. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation. Bratthauer GL, Saenger JS, Strauss BL. Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199 [Abstract] [Full Text] [Related]
2. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Werling RW, Hwang H, Yaziji H, Gown AM. Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930 [Abstract] [Full Text] [Related]
3. Naked nuclei revisited: p63 Immunoexpression. Reis-Filho JS, Albergaria A, Milanezi F, Amendoeira I, Schmitt FC. Diagn Cytopathol; 2002 Sep; 27(3):135-8. PubMed ID: 12203858 [Abstract] [Full Text] [Related]
4. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells. Hungermann D, Buerger H, Oehlschlegel C, Herbst H, Boecker W. BMC Cancer; 2005 Jul 28; 5():92. PubMed ID: 16050957 [Abstract] [Full Text] [Related]
5. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma. Rabban JT, Chen YY. Hum Pathol; 2008 Feb 28; 39(2):175-83. PubMed ID: 18206495 [Abstract] [Full Text] [Related]
6. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Edwards PC, Bhuiya T, Kelsch RD. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May 28; 97(5):613-9. PubMed ID: 15153875 [Abstract] [Full Text] [Related]
7. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Barbareschi M, Pecciarini L, Cangi MG, Macrì E, Rizzo A, Viale G, Doglioni C. Am J Surg Pathol; 2001 Aug 28; 25(8):1054-60. PubMed ID: 11474290 [Abstract] [Full Text] [Related]
8. p63 Expression of clear myoepithelial cells in epithelial-myoepithelial carcinoma of the salivary gland: a useful marker for naked myoepithelial cells in cytology. Kawahara A, Harada H, Yokoyama T, Kage M. Cancer; 2005 Aug 25; 105(4):240-5. PubMed ID: 15959915 [Abstract] [Full Text] [Related]
9. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast. Gould VE, Koukoulis GK, Jansson DS, Nagle RB, Franke WW, Moll R. Am J Pathol; 1990 Nov 25; 137(5):1143-55. PubMed ID: 1700618 [Abstract] [Full Text] [Related]
10. p63 is useful in the diagnosis of mammary metaplastic carcinomas. Tse GM, Tan PH, Chaiwun B, Putti TC, Lui PC, Tsang AK, Wong FC, Lo AW. Pathology; 2006 Feb 25; 38(1):16-20. PubMed ID: 16484002 [Abstract] [Full Text] [Related]
11. p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer. Ribeiro-Silva A, Ramalho LN, Garcia SB, Brandão DF, Chahud F, Zucoloto S. Histopathology; 2005 Nov 25; 47(5):458-66. PubMed ID: 16241993 [Abstract] [Full Text] [Related]
12. Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples. Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC. Cancer; 2003 Jun 25; 99(3):172-9. PubMed ID: 12811858 [Abstract] [Full Text] [Related]
13. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P, Akram M, Benezra R, Brogi E. Hum Pathol; 2006 Aug 25; 37(8):1032-41. PubMed ID: 16867866 [Abstract] [Full Text] [Related]
14. Ubiquitous p63 expression in human esophageal squamous cell carcinoma. Hara T, Kijima H, Yamamoto S, Kenmochi T, Kise Y, Tanaka H, Chino O, Shimada H, Takazawa K, Tanaka M, Inokuchi S, Makuuchi H. Int J Mol Med; 2004 Aug 25; 14(2):169-73. PubMed ID: 15254760 [Abstract] [Full Text] [Related]
15. Expression of c-kit in common benign and malignant breast lesions. Kondi-Pafiti A, Arkadopoulos N, Gennatas C, Michalaki V, Frangou-Plegmenou M, Chatzipantelis P. Tumori; 2010 Aug 25; 96(6):978-84. PubMed ID: 21388062 [Abstract] [Full Text] [Related]
16. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. O'Connell JT, Mutter GL, Cviko A, Nucci M, Quade BJ, Kozakewich HP, Neffen E, Sun D, Yang A, McKeon FD, Crum CP. Gynecol Oncol; 2001 Jan 25; 80(1):30-6. PubMed ID: 11136566 [Abstract] [Full Text] [Related]
17. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni A, Maffini F, Pruneri G, Fraggetta F, Cavallon A, Roz E, Iannucci A, Bresaola E, Viale G. J Pathol; 2002 Sep 25; 198(1):100-9. PubMed ID: 12210069 [Abstract] [Full Text] [Related]
18. STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histologic types. Strauss BL, Bratthauer GL, Tavassoli FA. Hum Pathol; 2006 May 25; 37(5):586-92. PubMed ID: 16647957 [Abstract] [Full Text] [Related]
19. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions. Pavlakis K, Zoubouli C, Liakakos T, Messini I, Keramopoullos A, Athanassiadou S, Kafousi M, Stathopoulos EN. Breast; 2006 Dec 25; 15(6):705-12. PubMed ID: 16384708 [Abstract] [Full Text] [Related]
20. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma. Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, Rosen PP. Am J Surg Pathol; 2009 Apr 25; 33(4):496-504. PubMed ID: 19047897 [Abstract] [Full Text] [Related] Page: [Next] [New Search]